Paydirt
ML
Insider

Mark N Lampert

Director

Mark N Lampert (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $63.0M of MLTX (3,750,000 sh across 3 lots, as filed), executed Mar 31.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$63.0M
shares × price, as filed
Last traded
Mar 31
Filed Apr 2

Median ADV $19.7M across their filed names

Open performance→
Volume by month
$63.0M$31.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · sells $63.0M
Buys $0 Sells $63.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
MLTX MoonLake Immunotherapeutics MLTX · 0 buys · 1 sell 1 filing
Recent filings
MLTXSALE MoonLake Immunotherapeutics View filing → $63.0M
3,750,000 sh across 3 lots
Exec Mar 31
Filed Apr 2 · 5:30 PM ET